Please wait a minute...

Frontiers of Medicine

Front. Med.    2010, Vol. 4 Issue (4) : 419-429
Research articles
Association of novel mutations and heplotypes in the preS region of hepatitis B virus with hepatocellular carcinoma
Jia-Xin XIE1,Jian-Hua YIN1,Qi ZHANG1,Rui PU1,Wen-Ying LU1,Hong-Wei ZHANG1,Guang-Wen CAO1,Jun ZHAO2,Hong-Yang WANG3,
1.Department of Epidemiology, Second Military Medical University, Shanghai 200433, China; 2.Department of Hepatobiliary Surgery, the 3rd Affiliated Hospital, Second Military Medical University, Shanghai 200433, China; 3.International Laboratory for Signal Transduction, the 3rd Affiliated Hospital, Second Military Medical University, Shanghai 200433, China;
Download: PDF(139 KB)  
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract The association of viral mutations and haplotypic carriages with mutations in the preS region of hepatitis B virus (HBV) genotypes B and C with hepatocellular carcinoma (HCC) is of great significance for the prediction of this malignancy, but it remains obscure. We analyzed the preS sequences of HBV genotypes B and C from 1172 HBV-infected subjects including 231 patients with HCC. As compared with the HBV-infected subjects without HCC, C2875T, G2946C, A3054C, C3060A, T3066C, C3116T, A3120C, G3191A, A1C, C7A, C10A, A31C, C76T, G105C, and G147C in both genotypes were significantly associated with increased risks of HCC. C2875A, G2950A, G2951A, A3054T, C3060T, T3066A, T3069G, A3120T, and G3191C were significantly associated with increased risks of HCC in genotype C, whereas these mutations were inversely associated with HCC in genotype B. Multivariate regression analyses showed that C76A/T was a novel factor independently associated with an increased risk of HCC, as compared with those without HCC. The frequencies of haplotypes 2964A-3116T-preS2 start codon wild-type-7C, 2964C-3116T-7A-76C, and 2964A-3116T-7C-76A/T were significantly higher in the patients with HCC (P<0.001), whereas a haplotypic carriage with a single mutation and another three wild-types were inversely associated with HCC. Conclusively, the association of HBV mutations in the preS region with HCC depends on HBV genotype and haplotypic carriage with two or more mutations that are each associated with an increased risk of HCC independently.
Keywords hepatitis B virus      hepatocellular carcinoma      mutation      genotype      haplotype      
Issue Date: 05 December 2010
 Cite this article:   
Wen-Ying LU,Jia-Xin XIE,Qi ZHANG, et al. Association of novel mutations and heplotypes in the preS region of hepatitis B virus with hepatocellular carcinoma[J]. Front. Med., 2010, 4(4): 419-429.
E-mail this article
E-mail Alert
Articles by authors
Wen-Ying LU
Jia-Xin XIE
Jian-Hua YIN
Rui PU
Hong-Wei ZHANG
Guang-Wen CAO
Nguyen V T, Law M G, Dore G J. Hepatitis B-related hepatocellular carcinoma:epidemiological characteristics and disease burden. J Viral Hepat, 2009, 16(7): 453–463
PMID: 19302335
El-Serag H B, Rudolph K L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology, 2007, 132(7): 2557–2576
PMID: 17570226
Yin J, Zhang H, Li C, Gao C, He Y, Zhai Y, Zhang P, Xu L, Tan X, Chen J, Cheng S, Schaefer S, Cao G. Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellularcarcinoma: compared with chronic hepatitis B and asymptomatic carrierstate in the same area. Carcinogenesis, 2008, 29(9): 1685–1691
PMID: 18192693
Liu S, Zhang H, Gu C, Yin J, He Y, Xie J, Cao G. Associations between hepatitis B virusmutations and the risk of hepatocellular carcinoma: a meta-analysis. J Natl Cancer Inst, 2009, 101(15): 1066–1082
PMID: 19574418
Cao G W. Clinical relevance and public health significance ofhepatitis B virus genomic variations. World J Gastroenterol, 2009, 15(46): 5761–5769
PMID: 19998495
Yin J, Zhang H, He Y, Xie J, Liu S, Chang W, Tan X, Gu C, Lu W, Wang H, Bi S, Cui F, Liang X, Schaefer S, Cao G. Distribution and hepatocellularcarcinoma-related viral properties of hepatitis B virus genotypesin Mainland China: a community-based study. Cancer Epidemiol Biomarkers Prev, 2010, 19(3): 777–786
PMID: 20160279
Kay A, Zoulim F. Hepatitis B virus genetic variability and evolution. Virus Res, 2007, 127(2): 164–176
PMID: 17383765
Chen B F, Liu C J, Jow G M, Chen P J, Kao J H, Chen D S. High prevalence and mapping of pre-S deletion in hepatitisB virus carriers with progressive liver diseases. Gastroenterology, 2006, 130(4): 1153–1168
PMID: 16618410
Gao Z Y, Li T, Wang J, Du J M, Li Y J, Li J, Lu F M, Zhuang H. Mutations in preS genes of genotype Chepatitis B virus in patients with chronic hepatitis B and hepatocellularcarcinoma. J Gastroenterol, 2007, 42(9): 761–768
PMID: 17876546
Cao Z, Bai X, Guo X, Jin Y, Qian G, Tu H. High prevalence of hepatitis B virus pre-S mutation andits association with hepatocellular carcinoma in Qidong, China. Arch Virol, 2008, 153(10): 1807–1812
PMID: 18726170
Fang Z L, Sabin C A, Dong B Q, Wei S C, Chen Q Y, Fang K X, Yang J Y, Huang J, Wang X Y, Harrison T J. Hepatitis B virus pre-S deletionmutations are a risk factor for hepatocellular carcinoma: a matchednested case-control study. J Gen Virol, 2008, 89(Pt 11): 2882–2890
PMID: 18931087
Yin J, Xie J, Zhang H, Shen Q, Han L, Lu W, Han Y, Li C, Ni W, Wang H, Cao G. Significant association of different preS mutations with hepatitis B-related cirrhosisor hepatocellular carcinoma. J Gastroenterol, 2010, 45(10): 1063–1071
PMID: 20419326
Chen J, Yin J, Tan X, Zhang H, Zhang H, Chen B, Chang W, Schaefer S, Cao G. Improved multiplex-PCR to identify hepatitis B virus genotypes A-F and subgenotypesB1, B2, C1 and C2. J Clin Virol, 2007, 38(3): 238–243
PMID: 17224304
Zhang H W, Yin J H, Li Y T, Li C Z, Ren H, Gu C Y, Wu H Y, Liang X S, Zhang P, Zhao J F, Tan X J, Lu W, Schaefer S, Cao G W. Risk factors for acute hepatitis B and its progression to chronichepatitis in Shanghai, China. Gut, 2008, 57(12): 1713–1720
PMID: 18755887
Shen T, Yan X M, Zou Y L, Gao J M, Dong H. Virologic characteristics of hepatitis B virus in patients infected via maternal-fetal transmission. World J Gastroenterol, 2008, 14(37): 5674–5682
PMID: 18837083
Bock C T, Tillmann H L, Maschek H J, Manns M P, Trautwein C. A preS mutation isolated from a patient with chronic hepatitis B infectionleads to virus retention and misassembly. Gastroenterology, 1997, 113(6): 1976–1982
PMID: 9394738
Hsieh Y H, Su I J, Wang H C, Chang W W, Lei H Y, Lai M D, Chang W T, Huang W. Pre-S mutant surface antigens in chronichepatitis B virus infection induce oxidative stress and DNA damage. Carcinogenesis, 2004, 25(10): 2023–2032
PMID: 15180947
Kekulé A S, Lauer U, Meyer M, Caselmann W H, Hofschneider P H, Koshy R. The preS2/S region of integratedhepatitis B virus DNA encodes a transcriptional transactivator. Nature, 1990, 343(6257): 457–461
PMID: 2153938
G?bel F, Taschner S, Jurkin J, Konradi S, Vaculik C, Richter S, Kneidinger D, Mühlbacher C, Bieglmayer C, Elbe-Bürger A, Strobl H. Reciprocal role of GATA-1 and vitamin D receptor in human myeloid dendritic celldifferentiation. Blood, 2009, 114(18): 3813–3821
PMID: 19721012
Andrieux L O, Fautrel A, Bessard A, Guillouzo A, Baffet G, Langou?t S. GATA-1 is essential in EGF-mediatedinduction of nucleotide excision repair activity and ERCC1 expressionthrough ERK2 in human hepatoma cells. Cancer Res, 2007, 67(5): 2114–2123
PMID: 17332341
Banerjee R, Caruccio L, Zhang Y J, McKercher S, Santella R M. Effects of carcinogen-induced transcription factors on the activationof hepatitis B virus expression in human hepatoblastoma HepG2 cellsand its implication on hepatocellular carcinomas. Hepatology, 2000, 32(2): 367–374
PMID: 10915744
Related articles from Frontiers Journals
[1] Amy Lee, Fa-Chyi Lee. Medical oncology management of advanced hepatocellular carcinoma 2019: a reality check[J]. Front. Med., 2020, 14(3): 273-283.
[2] Shengfen Wang, Yang Zhou, Bing Zhao, Xichao Ou, Hui Xia, Yang Zheng, Yuanyuan Song, Qian Cheng, Xinyang Wang, Yanlin Zhao. Characteristics of compensatory mutations in the rpoC gene and their association with compensated transmission of Mycobacterium tuberculosis[J]. Front. Med., 2020, 14(1): 51-59.
[3] Wenzhan Jing, Jue Liu, Min Liu. Eliminating mother-to-child transmission of HBV: progress and challenges in China[J]. Front. Med., 2020, 14(1): 21-29.
[4] Honglu Zhou, Songmei Wang, Lorenz von Seidlein, Xuanyi Wang. The epidemiology of norovirus gastroenteritis in China: disease burden and distribution of genotypes[J]. Front. Med., 2020, 14(1): 1-7.
[5] Xiaoxin Wu, Lanlan Xiao, Lanjuan Li. Research progress on human infection with avian influenza H7N9[J]. Front. Med., 2020, 14(1): 8-20.
[6] Yang Zhang, Fang Wang, Xue Chen, Wenjing Liu, Jiancheng Fang, Mingyu Wang, Wen Teng, Panxiang Cao, Hongxing Liu. Mutation profiling of 16 candidate genes in de novo acute myeloid leukemia patients[J]. Front. Med., 2019, 13(2): 229-237.
[7] Qiongna Dong, Bizhi Shi, Min Zhou, Huiping Gao, Xiaoying Luo, Zonghai Li, Hua Jiang. Growth suppression of colorectal cancer expressing S492R EGFR by monoclonal antibody CH12[J]. Front. Med., 2019, 13(1): 83-93.
[8] Min Zhang, Jingwen Yang, Wenjing Hua, Zhong Li, Zenghui Xu, Qijun Qian. Monitoring checkpoint inhibitors: predictive biomarkers in immunotherapy[J]. Front. Med., 2019, 13(1): 32-44.
[9] Renyu Zhang, Zhao Zhang, Zekun Liu, Ding Wei, Xiaodong Wu, Huijie Bian, Zhinan Chen. Adoptive cell transfer therapy for hepatocellular carcinoma[J]. Front. Med., 2019, 13(1): 3-11.
[10] Liru Qiu, Fengjie Yang, Yonghua He, Huiqing Yuan, Jianhua Zhou. Clinical characterization and diagnosis of cystic fibrosis through exome sequencing in Chinese infants with Bartter-syndrome-like hypokalemia alkalosis[J]. Front. Med., 2018, 12(5): 550-558.
[11] Shasha Zhu, Huimin Zhang, Li Bai. NKT cells in liver diseases[J]. Front. Med., 2018, 12(3): 249-261.
[12] Dong Wang, Min Tian, Guanglin Cui, Dao Wen Wang. Antithrombin deficiency and decreased protein C activity in a young man with venous thromboembolism: a case report[J]. Front. Med., 2018, 12(3): 319-323.
[13] Guangbiao Zhou, Xinchun Zhao. Carcinogens that induce the A:T>T:A nucleotide substitutions in the genome[J]. Front. Med., 2018, 12(2): 236-238.
[14] Haican Liu, Yuanyuan Zhang, Zhiguang Liu, Jinghua Liu, Yolande Hauck, Jiao Liu, Haiyan Dong, Jie Liu, Xiuqin Zhao, Bing Lu, Yi Jiang, Gilles Vergnaud, Christine Pourcel, Kanglin Wan. Associations between Mycobacterium tuberculosis Beijing genotype and drug resistance to four first-line drugs: a survey in China[J]. Front. Med., 2018, 12(1): 92-97.
[15] Min Yu, Zonghai Li. Natural killer cells in hepatocellular carcinoma: current status and perspectives for future immunotherapeutic approaches[J]. Front. Med., 2017, 11(4): 509-521.
Full text